Viatris Operating Margin 2010-2025 | VTRS

Current and historical operating margin for Viatris (VTRS) over the last 10 years. The current operating profit margin for Viatris as of June 30, 2025 is 20.40%.
Viatris Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $14.12B $-2.60B -18.44%
2025-03-31 $14.33B $-3.08B -21.47%
2024-12-31 $14.74B $0.01B 0.07%
2024-09-30 $15.05B $-0.26B -1.75%
2024-06-30 $15.24B $-0.04B -0.25%
2024-03-31 $15.36B $0.57B 3.72%
2023-12-31 $15.43B $0.77B 4.97%
2023-09-30 $15.47B $1.02B 6.60%
2023-06-30 $15.60B $1.13B 7.23%
2023-03-31 $15.80B $1.31B 8.28%
2022-12-31 $16.26B $1.62B 9.93%
2022-09-30 $16.73B $1.74B 10.39%
2022-06-30 $17.19B $1.54B 8.94%
2022-03-31 $17.65B $0.94B 5.32%
2021-12-31 $17.89B $-0.03B -0.19%
2021-09-30 $17.17B $-0.84B -4.88%
2021-06-30 $15.60B $-0.84B -5.41%
2021-03-31 $13.76B $-0.66B -4.81%
2020-12-31 $11.95B $-0.21B -1.77%
2020-09-30 $11.51B $0.94B 8.18%
2020-06-30 $11.50B $0.92B 7.95%
2020-03-31 $11.63B $0.88B 7.54%
2019-12-31 $11.50B $0.72B 6.23%
2019-09-30 $11.39B $0.68B 5.94%
2019-06-30 $11.29B $0.69B 6.12%
2019-03-31 $11.25B $0.77B 6.88%
2018-12-31 $11.43B $0.91B 7.92%
2018-09-30 $11.59B $1.09B 9.42%
2018-06-30 $11.72B $1.07B 9.14%
2018-03-31 $11.87B $1.37B 11.51%
2017-12-31 $11.91B $1.44B 12.08%
2017-09-30 $11.94B $1.33B 11.16%
2017-06-30 $12.01B $0.88B 7.36%
2017-03-31 $11.61B $0.82B 7.07%
2016-12-31 $11.08B $0.70B 6.31%
2016-09-30 $10.30B $0.81B 7.86%
2016-06-30 $9.94B $1.54B 15.52%
2016-03-31 $9.75B $1.41B 14.44%
2015-12-31 $9.43B $1.46B 15.49%
2015-09-30 $9.02B $1.43B 15.85%
2015-06-30 $8.41B $1.32B 15.74%
2015-03-31 $7.88B $1.27B 16.16%
2014-12-31 $7.72B $1.35B 17.53%
2014-09-30 $7.45B $1.23B 16.56%
2014-06-30 $7.13B $1.08B 15.12%
2014-03-31 $6.99B $1.16B 16.60%
2013-12-31 $6.91B $1.14B 16.44%
2013-09-30 $6.82B $1.13B 16.50%
2013-06-30 $6.86B $1.12B 16.34%
2013-03-31 $6.85B $1.07B 15.68%
2012-12-31 $6.80B $1.11B 16.33%
2012-09-30 $6.61B $1.09B 16.56%
2012-06-30 $6.38B $1.03B 16.07%
2012-03-31 $6.27B $1.04B 16.66%
2011-12-31 $6.13B $1.01B 16.39%
2011-09-30 $6.03B $0.85B 14.12%
2011-06-30 $5.81B $0.82B 14.11%
2011-03-31 $5.61B $0.74B 13.11%
2010-12-31 $5.45B $0.72B 13.25%
2010-09-30 $5.37B $0.69B 12.82%
2010-06-30 $5.28B $0.52B 9.76%
2010-03-31 $5.18B $0.50B 9.57%
2009-12-31 $5.09B $0.52B 10.27%
Sector Industry Market Cap Revenue
Medical Medical Services $12.417B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $151.660B 28.13
CVS Health (CVS) United States $90.432B 11.25
Elevance Health (ELV) United States $71.280B 9.59
Cencora (COR) United States $56.729B 18.89
DiDi Global (DIDIY) China $27.580B 29.30
Labcorp Holdings (LH) United States $23.117B 18.37
Natera (NTRA) United States $22.728B 0.00
BioMerieux (BMXMF) France $17.547B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.699B 0.00
ICON (ICLR) Ireland $14.199B 13.66
Medpace Holdings (MEDP) United States $13.025B 34.47
CochLear (CHEOY) Australia $12.814B 0.00
Solventum (SOLV) United States $12.753B 13.16
Caris Life Sciences,�Inc (CAI) United States $11.052B 0.00
Revvity (RVTY) United States $10.928B 19.25
Avantor (AVTR) United States $9.047B 13.27
Sonic Healthcare (SKHHY) Australia $8.007B 0.00
Charles River Laboratories (CRL) United States $7.965B 15.11
HealthEquity (HQY) United States $7.767B 34.02
Bausch + Lomb (BLCO) Canada $5.289B 35.57
Sotera Health (SHC) United States $4.667B 26.08
BrightSpring Health Services (BTSG) United States $4.406B 33.61
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
KindlyMD (NAKA) United States $3.810B 0.00
GeneDx Holdings (WGS) United States $3.696B 84.65
Alignment Healthcare (ALHC) United States $3.137B 0.00
Concentras Parent (CON) United States $3.031B 19.23
Surgery Partners (SGRY) United States $3.031B 38.13
Organon (OGN) United States $2.451B 2.67
Premier (PINC) United States $2.070B 19.19
Progyny (PGNY) United States $2.023B 42.78
Ardent Health (ARDT) United States $1.858B 7.17
PACS (PACS) United States $1.836B 0.00
GoodRx Holdings (GDRX) United States $1.584B 26.82
Pediatrix Medical (MD) United States $1.481B 9.89
Teladoc Health (TDOC) United States $1.357B 0.00
Establishment Labs Holdings (ESTA) $1.264B 0.00
Omada Health (OMDA) $1.227B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.962B 0.00
Embecta (EMBC) United States $0.841B 4.92
AMN Healthcare Services Inc (AMN) United States $0.795B 9.83
CareDx (CDNA) United States $0.690B 12.72
QDM (QDMI) Hong Kong, SAR China $0.641B 110.00
Performant Healthcare (PHLT) United States $0.599B 0.00
Agilon Health (AGL) United States $0.551B 0.00
Nutex Health (NUTX) United States $0.513B 7.77
InnovAge Holding (INNV) United States $0.505B 0.00
Sonida Senior Living (SNDA) United States $0.501B 0.00
Auna S.A (AUNA) Luxembourg $0.457B 6.87
SBC Medicals (SBC) United States $0.446B 9.75
COMPASS Pathways (CMPS) United Kingdom $0.442B 0.00
Enhabit (EHAB) United States $0.415B 27.30
So-Young (SY) China $0.411B 0.00
Oncology Institute (TOI) United States $0.354B 0.00
LifeMD (LFMD) United States $0.300B 0.00
Beauty Health (SKIN) United States $0.280B 0.00
Shoulder Innovations (SI) United States $0.194B 0.00
DocGo (DCGO) United States $0.168B 0.00
Ascend Wellness Holdings (AAWH) United States $0.145B 0.00
Sera Prognostics (SERA) United States $0.090B 0.00
Biodesix (BDSX) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.052B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.039B 0.00
Basel Medical Group (BMGL) Singapore $0.037B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
ModivCare (MODV) United States $0.015B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
OSR Holdings (OSRH) United States $0.011B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
XWELL (XWEL) United States $0.006B 0.00
INVO Fertility (IVF) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00